Oct 19
Earnings call
Q2 2027 earnings call
Rossari Biotech Limited reported Q2 FY27 revenue of Rs. 697.6 crore, up 19% Y-o-Y, and EBITDA of Rs. 87 crore, up 21%, with a 12.5% margin. The Board approved leasing land for a Greenfield manufacturing facility in Saudi Arabia.